International Clinical Trial: Determination of the ED50 and ED95 of Remimazolam Combined with Target-Controlled Infusion of Sufentanil for Attenuating Hemodynamic Responses to Endotracheal Intubation and Laryngeal Mask Airway Insertion

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133564) titled 'Determination of the ED50 and ED95 of Remimazolam Combined with Target-Controlled Infusion of Sufentanil for Attenuating Hemodynamic Responses to Endotracheal Intubation and Laryngeal Mask Airway Insertion' on Sept. 29.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Affiliated Hospital of Guizhou Medical University

Condition: Cardiovascular stress response induced by tracheal intubation/laryngeal mask airway placement during general anesthesia induction

Intervention: Test Group 1:Remimazolam 0.2 mg/kg was administered intravenously, and sufentanil TCI was initiated when loss of...